查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018724

机器人内视镜设备市场：依设备类型、技术、应用和最终用户划分－2026-2032年全球市场预测

Robotic Endoscopy Devices Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，机器人内视镜设备市场价值将达到 37 亿美元，到 2026 年将成长至 43.5 亿美元，到 2032 年将达到 125.9 亿美元，复合年增长率为 19.12%。

主要市场统计数据
基准年 2025 37亿美元
预计年份：2026年 43.5亿美元
预测年份 2032 125.9亿美元
复合年增长率 (%) 19.12%

简要概述了各专业领域内机器人内视镜技术的进步、推动临床应用的因素以及塑造其发展趋势的策略挑战。

机器人内视镜领域融合了微创手术和数位外科辅助技术的创新成果。近年来，执行器小型化、影像解析度和感测器整合方面的进步，彻底改变了临床医生对多个器官系统进行复杂诊断和治疗性介入的方式。因此，与传统内视镜平台相比，临床团队能够获得更高的操作便利性、更短的手术时间和更佳的人体工学体验。

分析正在重新定义临床工作流程和实施趋势的整合技术创新、监管变化和经营模式。

由于技术、临床和商业性因素的融合，机器人内视镜领域正经历着一场变革。微型化的致动器和改进的触觉回馈使得在解剖结构受限的区域内能够进行更精确的操作，而光学系统和人工智慧辅助视觉化技术的进步则增强了病变检测和手术决策支援。这些技术要素并非孤立发挥作用，而是透过使更复杂的内视镜手术介入成为可能，从而重塑了临床路径，使医生能够在管腔内而非透过开放性手术或腹腔镜手术进行操作。

评估近期美国关税变化如何重塑全球供应链、筹资策略以及机器人内视相关人员的采购决策。

近年来，源自美国的政策变革和贸易措施重新引发了人们对全球医疗设备供应链韧性和先进治疗平台成本结构的关注。关税调整对价值链上的多个环节都造成了压力，从精密组件和成像模组到成品，都可能受到影响，并可能影响製造地的选择、关键子系统的采购方式以及战略伙伴关係中首选供应商的确定。

详细的細項分析揭示了医疗设备类型、临床应用、平台技术、终端用户环境和销售管道如何推动采用和差异化。

不同类型的医疗设备对于临床团队、采购部门和研发人员确定投资优先顺序至关重要。诊断系统兼具切片检查功能和影像平台，因其能够在不造成显着组织损伤的情况下提高早期检测和病灶定性能力而备受重视。另一方面，治疗器械则着重于介入治疗功能，例如消融、止血和切除，其机器人架构能够实现稳定、精确的能量传输和可控的组织操作。

区域趋势：本节详细介绍了不同的医疗保健系统、法规环境和采购模式如何影响机器人内视镜技术创新的采用和推广。

地理因素影响技术引进週期、监管互动和商业化路径。在美洲，密集的大学医院网路、大规模综合医疗保健系统和私人门诊机构为早期临床检验和稳健的商业模式提供了沃土。该地区的报销框架和医疗采购流程影响着那些能够显着提高手术效率并带来可重复临床结果的平台的优先顺序。

从企业层面洞察产品差异化、临床证据的取得、伙伴关係、决定竞争地位的营运措施。

机器人内视镜领域的竞争动态体现了传统医疗设备巨头进军机器人领域与敏捷的新兴参与企业专注于颠覆性平台功能之间的平衡。主要企业的策略包括：透过研究人员主导和公司支持的研究来产生临床证据；开发整合服务和培训方案以降低应用门槛；以及与医院和学术机构建立伙伴关係，以加速实际检验。

为开发人员、医疗保健提供者和销售团队提供切实可行的策略建议，以加速产品采用、降低供应风险并确保可持续的临床价值。

产业领导者应优先考虑将设备创新与切实可行的部署策略相结合的综合方法。首先，他们必须投资于强有力的临床证据项目，以解决支付方和医疗服务提供者重视的真实世界终点，并确保将培训途径整合到商业部署中，从而降低推广应用的障碍。其次，他们必须透过区域采购、关键零件的双重采购安排以及与契约製造建立合作关係来增强供应链韧性，最大限度地降低贸易中断和关税相关成本压力的风险。

清晰的调查方法，详细说明了与关键相关人员的互动、观察分析以及用于产生可操作见解的二手技术和监管审查。

本执行摘要所依据的综合研究采用多方面方法，结合了与关键相关人员的沟通以及相关的技术和法规审查。关键资讯包括与临床负责人、采购主管和设备工程师进行结构化访谈，以了解实际部署中遇到的障碍、培训需求和组件采购流程。除这些访谈外，还开展了有针对性的实地考察和监考观察，以深入了解工作流程影响和使用者体验的细微差别。

摘要重点阐述了临床潜力、实施的操作前提条件以及决定长期成功的策略要素。

机器人辅助内视镜在微创医学的广泛发展中占据着至关重要的地位，具有提高诊断准确性和减轻患者治疗性介入负担的实际潜力。驱动技术、先进成像技术和智慧软体的整合，使其在支气管镜学、消化内科、耳鼻喉科和泌尿系统等领域得以应用，而多样化的平台技术则满足了广泛的临床和操作需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：机器人内视镜设备市场：依设备类型划分

  • 诊断
    • 切片检查
    • 诊断影像
  • 治疗
    • 消融术
    • 止血
    • 切除

第九章：机器人内视镜设备市场：依技术划分

  • 胶囊内视镜
  • 柔性机器人内视镜
  • 刚性机器人内视镜

第十章：机器人内视镜设备市场：依应用领域划分

  • 支气管
  • 消化系统
    • 下消化道
    • 上消化道
  • 耳鼻喉科
  • 泌尿系统

第十一章：机器人内视镜设备市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院
  • 研究机构

第十二章：机器人内视镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：机器人内视镜设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：机器人内视镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国机器人内视镜设备市场

第十六章：中国机器人内视镜设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • Asensus Surgical, Inc.
  • avateramedical GmbH
  • Boston Scientific Corporation
  • Brainlab AG
  • CMR Surgical Ltd.
  • Cook Group Incorporated
  • EndoMaster Pte Ltd
  • Endotics
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Olympus Corporation
  • Otsuka Holdings Co., Ltd.
  • Renishaw PLC
  • Ronovo Surgical
  • Stryker Corporation
  • Virtuoso Surgical, Inc.
Product Code: MRR-CA17E905E71D

The Robotic Endoscopy Devices Market was valued at USD 3.70 billion in 2025 and is projected to grow to USD 4.35 billion in 2026, with a CAGR of 19.12%, reaching USD 12.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.70 billion
Estimated Year [2026] USD 4.35 billion
Forecast Year [2032] USD 12.59 billion
CAGR (%) 19.12%

Concise introduction outlining technological evolution, clinical adoption drivers, and strategic tensions shaping robotic endoscopy across specialties

The field of robotic endoscopy sits at the intersection of minimally invasive procedural innovation and digital surgical augmentation. Recent advances in actuator miniaturization, imaging fidelity, and sensor integration have reshaped how clinicians approach complex diagnostic and therapeutic interventions across multiple organ systems. As a result, clinical teams are increasingly able to perform procedures with enhanced dexterity, reduced procedure times, and improved ergonomics compared with legacy endoscopic platforms.

Alongside technical progress, an expanding portfolio of flexible and rigid platforms, plus swallowable capsule technologies, has broadened clinical applicability from bronchial and otolaryngological procedures to comprehensive gastrointestinal and urological workflows. This diversification is enabling device suppliers to pursue specialized applications while healthcare providers evaluate pathways to adopt robotics where clinical benefit and workflow efficiency align.

Transitions in regulatory expectations, reimbursement frameworks, and hospital procurement priorities are accelerating adoption choices. Consequently, stakeholders must balance clinical outcomes with capital deployment, training pathways, and service delivery models. The remainder of this executive summary synthesizes those dynamics and frames practical considerations for clinical leaders, device developers, and commercial strategists operating in the robotic endoscopy space.

Analysis of converging technological innovations, regulatory shifts, and commercial models that are redirecting clinical workflows and adoption dynamics

The robotic endoscopy landscape is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. Miniaturized actuators and improved haptic feedback have enabled more precise manipulation in constrained anatomies, while advances in optical systems and AI-assisted visualization are enhancing lesion detection and intra-procedural decision support. These technology vectors are not acting in isolation; they are reshaping clinical pathways by enabling more complex interventions to be performed endolumenally rather than through open or laparoscopic approaches.

Commercial models are evolving in parallel. Device developers are experimenting with outcome-based procurement arrangements, service contracts, and bundled offerings that include training and lifecycle support. Hospitals and ambulatory providers are increasingly evaluating total cost of ownership rather than capital price alone, which places a premium on modular platforms that can support multiple use cases across procedural areas. Meanwhile, regulatory bodies are clarifying pathways for software updates and AI-enabled features, which has implications for product roadmaps and post-market surveillance obligations.

Operationally, integration into established clinical workflows remains a critical barrier and opportunity. Clinical champions are essential to accelerate adoption, but effective training curricula, proctoring models, and demonstrable workflow efficiencies are equally important. As the market matures, collaboration across device manufacturers, health systems, and academic centers will determine which innovations transition from proof-of-concept to standard of care.

Assessment of how recent United States tariff changes are reshaping global supply chains, sourcing strategies, and procurement decisions for robotic endoscopy stakeholders

Policy changes and trade measures originating from the United States in recent years have brought renewed attention to the resilience of global medical device supply chains and the cost structures of advanced procedural platforms. Tariff adjustments exert pressure across multiple nodes of the value chain, from precision components and imaging modules to finished assemblies, and they can influence decisions about where to manufacture, how to source critical subsystems, and which suppliers to prioritize for strategic partnerships.

In response, many manufacturers have accelerated supplier diversification and pursued nearshoring or regional manufacturing strategies to mitigate exposure to tariff volatility. These initiatives are often accompanied by redesign efforts aimed at substituting tariff-exposed components with alternatives that are readily sourced within target regions, and by renegotiated commercial terms with contract manufacturers and logistics providers. Healthcare providers and group purchasing organizations have also reacted by reassessing procurement frameworks to account for potential price variability and longer lead times for specialized instrumentation.

Regulatory compliance and import documentation practices have become more central to commercial planning, and firms are investing in customs expertise to minimize administrative friction. At the same time, alternative strategies such as increased vertical integration or dual-sourcing of critical components are being explored to preserve continuity of supply. Overall, the cumulative impact of tariff-related pressures has emphasized resilience, flexibility, and a willingness to reengineer supply chains to protect product availability and control unit costs under shifting trade conditions.

In-depth segmentation analysis clarifying how device type, clinical application, platform technology, end-user environment, and sales channel drive adoption and differentiation

Device type distinctions are central to how clinical teams, purchasing groups, and developers prioritize investments. Diagnostic systems, which encompass both biopsy-capable devices and imaging-focused platforms, are valued for their ability to enhance early detection and lesion characterization without extensive tissue disruption. Therapeutic devices, on the other hand, emphasize intervention capabilities such as ablation, hemostasis, and resection, where the robotic architecture can deliver stable, precise energy delivery and controlled tissue manipulation.

Application-driven segmentation determines clinical workflows and training requirements. Bronchial platforms face challenges related to airway access and sensor stabilization, while gastrointestinal applications require navigation across proximal and distal anatomy with distinct imaging and tool-delivery needs for upper and lower procedures. Otolaryngological and urological uses impose their own ergonomic and instrument-design constraints, reinforcing the need for differentiated platform features.

Technology choices-capsule endoscopes, flexible robotic endoscopes, and rigid robotic endoscopes-create trade-offs among patient comfort, controllability, and instrument payload. Capsule systems emphasize noninvasiveness and diagnostic convenience, flexible robotic platforms prioritize reach and navigation in tortuous anatomies, and rigid platforms deliver stability and force for certain therapeutic interventions. End-user settings influence purchasing rationale and support models; ambulatory surgical centers seek compact, turnaround-efficient systems, clinics optimize for outpatient diagnostics and referral pathways, hospitals focus on integrated suites that support multidisciplinary procedures, and research institutes prioritize modularity and access for iterative development. Sales channels further affect adoption speed and support intensity, with direct-sales approaches enabling tailored service agreements and distribution models offering broader geographic coverage and scalability.

Regional intelligence detailing how distinct healthcare systems, regulatory environments, and procurement models influence adoption and scaling of robotic endoscopy innovations

Geographic dynamics shape technology adoption cycles, regulatory engagement, and commercialization pathways. In the Americas, a dense network of academic medical centers, large integrated health systems, and private ambulatory facilities creates fertile ground for early clinical validation and high-touch commercial models. Reimbursement frameworks and institutional procurement processes in this region influence the prioritization of platforms that demonstrate clear procedural efficiency gains and reproducible clinical outcomes.

The Europe, Middle East & Africa region presents a heterogeneous landscape where regulatory harmonization, national procurement policies, and diverse healthcare delivery models affect product rollout strategies. In some countries, centralized purchasing and rigorous health-technology assessment pathways require robust evidence generation and local clinical partnerships, while in others faster adoption is enabled by less centralized procurement and capital investment from private providers.

Asia-Pacific encompasses a wide spectrum of healthcare systems, from highly specialized tertiary centers to rapidly expanding ambulatory care networks. Demand drivers in this region include large patient volumes for gastrointestinal and bronchial conditions, cost-sensitive procurement practices, and increasing investment in domestic manufacturing and R&D capabilities. Across all regions, tailored engagement that respects local reimbursement realities, clinical practice patterns, and supply-chain considerations will be necessary to translate technological promise into sustained clinical use.

Strategic company-level insights on product differentiation, clinical evidence pursuits, partnerships, and operational moves that determine competitive positioning

Competitive dynamics in the robotic endoscopy space reflect a balance between established medical device incumbents expanding into robotics and agile newcomers focused on disruptive platform features. Key company strategies include pursuing clinical evidence generation through investigator-initiated and sponsored studies, developing integrated service and training bundles to reduce adoption friction, and forging partnerships with hospitals and academic centers to accelerate real-world validation.

Product differentiation is being driven by unique value propositions such as modular instrument ecosystems, software-driven visualization and decision-support, and lifecycle service packages that include remote monitoring and predictive maintenance. Firms that can demonstrate interoperability with hospital ecosystems, robust regulatory pathways for software updates, and clear clinician training curricula gain an advantage in procurement discussions.

Strategic corporate activity has included selective vertical integration of critical subsystems, alliances with imaging and analytics companies, and targeted investments in manufacturing capacity to secure supply continuity. These moves reflect a pragmatic recognition that success in this domain requires not only compelling clinical performance but also dependable post-market support and the ability to scale commercially in diverse healthcare environments.

Actionable strategic recommendations for developers, providers, and commercial teams to accelerate adoption, mitigate supply risk, and secure durable clinical value

Industry leaders should prioritize an integrated approach that aligns device innovation with pragmatic adoption strategies. First, invest in robust clinical evidence programs that address real-world endpoints valued by payers and providers, and ensure that training pathways are embedded into commercial rollouts to reduce adoption friction. Second, strengthen supply-chain resilience through regional sourcing, dual-sourcing arrangements for critical components, and partnerships with contract manufacturers to minimize exposure to trade disruptions and tariff-related cost pressures.

Third, design commercial models that reflect institutional purchasing preferences by offering flexible financing, outcome-linked services, and scalable support packages tailored to ambulatory centers, clinics, and hospitals. Fourth, emphasize interoperability and software architecture that supports continuous improvement while satisfying evolving regulatory expectations for software as a medical device. Finally, pursue partnerships with clinical centers of excellence and research institutes to accelerate iterative product refinement and build compelling case studies that support broader reimbursement and procurement discussions.

By executing against these priorities, leaders can reduce time-to-adoption, mitigate operational risk, and position their platforms for durable clinical and commercial impact across diverse healthcare settings.

Clear research methodology detailing primary stakeholder engagement, observational analysis, and secondary technical and regulatory review used to produce actionable insights

The research synthesis behind this executive summary is grounded in a multi-method approach that combines primary stakeholder engagement with secondary technical and regulatory review. Primary inputs included structured interviews with clinical leaders, procurement executives, and device engineers to capture real-world adoption barriers, training requirements, and component sourcing practices. These conversations were complemented by targeted site visits and proctoring session observations to understand workflow implications and user experience nuances.

Secondary sources were consulted to contextualize technological trends, regulatory guidance, and public policy developments affecting cross-border trade and device classification. The analytical framework prioritized triangulation of qualitative insights with documented regulatory decisions and published clinical literature to ensure robustness. Where applicable, scenario assessments were used to evaluate the implications of supply-chain disruptions, policy shifts, and technology maturation for commercial planning.

Throughout the process, attention was given to transparency of assumptions, clear documentation of interview protocols, and rigorous review of clinical claims against publicly available evidence. The methodology supports practical recommendations while acknowledging areas where further primary research or long-term outcomes data would strengthen decision confidence.

Concluding synthesis emphasizing clinical promise, operational preconditions for adoption, and the strategic attributes that will determine long-term success

Robotic endoscopy occupies a pivotal position in the broader trajectory of minimally invasive care, offering tangible potential to improve diagnostic accuracy and enable therapeutic interventions with lower patient burden. The convergence of improved actuation, advanced imaging, and intelligent software is unlocking applications across bronchial, gastrointestinal, otolaryngological, and urological care pathways, while diverse platform technologies are responding to varied clinical and operational needs.

Nevertheless, success will hinge on more than technical performance. Sustained adoption requires thoughtfully designed training, procurement models that align incentives for providers and vendors, and resilient supply chains that can withstand geopolitical and tariff-related pressures. Regional differences in regulatory expectations and reimbursement mechanisms will continue to shape which innovations scale rapidly and which require extended evidence-generation periods.

In sum, the next phase of development will favor organizations that combine clinical rigor with operational excellence, strategic partnerships, and adaptive commercialization strategies. Stakeholders who integrate those capabilities can convert technological promise into measurable clinical and organizational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic Endoscopy Devices Market, by Device Type

  • 8.1. Diagnostic
    • 8.1.1. Biopsy
    • 8.1.2. Imaging
  • 8.2. Therapeutic
    • 8.2.1. Ablation
    • 8.2.2. Hemostasis
    • 8.2.3. Resection

9. Robotic Endoscopy Devices Market, by Technology

  • 9.1. Capsule Endoscope
  • 9.2. Flexible Robotic Endoscope
  • 9.3. Rigid Robotic Endoscope

10. Robotic Endoscopy Devices Market, by Application

  • 10.1. Bronchial
  • 10.2. Gastrointestinal
    • 10.2.1. Lower Gastrointestinal
    • 10.2.2. Upper Gastrointestinal
  • 10.3. Otolaryngological
  • 10.4. Urological

11. Robotic Endoscopy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Robotic Endoscopy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Robotic Endoscopy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Robotic Endoscopy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Robotic Endoscopy Devices Market

16. China Robotic Endoscopy Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. Asensus Surgical, Inc.
  • 17.7. avateramedical GmbH
  • 17.8. Boston Scientific Corporation
  • 17.9. Brainlab AG
  • 17.10. CMR Surgical Ltd.
  • 17.11. Cook Group Incorporated
  • 17.12. EndoMaster Pte Ltd
  • 17.13. Endotics
  • 17.14. Globus Medical, Inc.
  • 17.15. Intuitive Surgical, Inc.
  • 17.16. KARL STORZ SE & Co. KG
  • 17.17. Medtronic PLC
  • 17.18. MicroPort Scientific Corporation
  • 17.19. Olympus Corporation
  • 17.20. Otsuka Holdings Co., Ltd.
  • 17.21. Renishaw PLC
  • 17.22. Ronovo Surgical
  • 17.23. Stryker Corporation
  • 17.24. Virtuoso Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)